[1]
Kameo, S.Y. et al. 2021. Hematotoxicity and functional impacts related to chemotherapy with doxorubicin and cyclophosphamide for invasive ductal breast carcinoma: a study in clinical records. Journal of Health & Biological Sciences. 9, 1 (dez. 2021), 1–8. DOI:https://doi.org/10.12662/2317-3076jhbs.v9i1.3864.p1-8.2021.